Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States

por Kim, Nina, Wang, Jessie, Burudpakdee, Chakkarin, Song, Yan, Ramasamy, Abhilasha, Xie, Yanwen, Sun, Rochelle, Kumar, Neela, Wu, Eric Q, Sullivan, Sean D
Publicado 2022